An Exploratory Study for PD-1 Antibody JS001 in Participants With Microsatellite Instability-high (MSI-H) Advanced or Recurrent Colorectal Cancer
Latest Information Update: 08 Oct 2021
At a glance
- Drugs Toripalimab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 05 Oct 2019 Status changed from not yet recruiting to recruiting.
- 01 Oct 2019 New trial record